An international study in 35 countries which commenced in 2011 and involved 4685 people with HIV, reported in May that starting antiretroviral treatment soon after diagnosis protects a person’s health. The START study showed compelling evidence that the benefits of commencing antiretroviral treatment immediately at CD4 counts above 500 far outweigh the risks. The findings will affect treatment guidelines around the world concerning when to start treatment for HIV infection.
The Kirby Institute in Australia was one of the bodies co-ordinating the study. If you would like to read more about this important study you can read about it on the Kirby Institute website.